UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007855 |
|---|---|
| Receipt number | R000009140 |
| Scientific Title | Study for the add-on effect of vitamin K to Sorafenib treatment for hepatocellular carcinoma |
| Date of disclosure of the study information | 2012/04/28 |
| Last modified on | 2025/07/13 17:18:54 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Study for the add-on effect of vitamin K to Sorafenib treatment for hepatocellular carcinoma
Acronym
Sorafenib + vitamin K therapy for HCC
Scientific Title
Study for the add-on effect of vitamin K to Sorafenib treatment for hepatocellular carcinoma
Scientific Title:Acronym
Sorafenib + vitamin K therapy for HCC
Region
| Japan |
Condition
Condition
hepatocellular carcinoma
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of the add-on effect of vitamin K to sorafenib treatment for hepatocellular carcinoma
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Effect for overall survival
Key secondary outcomes
Evaluation of safety
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Srafenib + vitamin K combination therapy
Interventions/Control_2
Sorafenib monotherapy
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 85 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Patients with chronic hepatitis or compensated liver cirrhosis (Child-Pugh classification A), who do not have indication for either surgical resection nor radio frequency ablation or percutaneous ethanol infusion
Key exclusion criteria
Patients with uncontrollable infection
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yoshimichi Haruna |
Organization
Osaka General Medical Center
Division name
Department of Gastroenterology and Hepatology
Zip code
Address
3-1-56 Bandaihigashi, Sumiyoshiku, Osaka
TEL
06-6692-1201
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Osaka General Medical Center
Division name
IRB
Zip code
Address
TEL
Homepage URL
chiken@gh.opho.jp
Sponsor or person
Institute
Osaka General Medical Center
Institute
Department
Personal name
Funding Source
Organization
Osaka General Medical Center
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 04 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2012 | Year | 02 | Month | 15 | Day |
Date of IRB
| 2012 | Year | 04 | Month | 15 | Day |
Anticipated trial start date
| 2012 | Year | 05 | Month | 01 | Day |
Last follow-up date
| 2024 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
| 2024 | Year | 12 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2012 | Year | 04 | Month | 28 | Day |
Last modified on
| 2025 | Year | 07 | Month | 13 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009140
